In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Exelon's current price exceeds the PERT-weighted fair value by 19.4%, indicating potential overvaluation amid wide Monte Carlo volatility (68.14 SD) and 55.9% downside risk. Confidence is high in valuation but financial health scores reflect fair liquidity and leverage. Valuation metrics diverge sharply, revealing significant uncertainty and risk.